Osimertinib Overcomes Alectinib Resistance Caused by Amphiregulin in a Leptomeningeal Carcinomatosis Model of EML4-ALK Lung Cancer

被引：0
|
作者：
Arai, S. [1 ]
Takeuchi, S. [1 ]
Fukuda, K. [1 ]
Nishiyama, A. [1 ]
Tanimoto, A. [1 ]
Taniguchi, H. [1 ]
Satouchi, M. [2 ]
Nanjo, S. [1 ]
Katayama, R. [3 ]
Nishio, M. [4 ]
Zheng, M. [5 ]
Wu, Y. [6 ,7 ]
Yano, S. [1 ]
机构：
[1] Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa, Japan
[2] Hyogo Canc Ctr, Akashi, Hyogo, Japan
[3] Japanese Fdn Canc Res, Canc Chemotherapy Ctr, Tokyo, Japan
[4] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[5] Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[6] Guangdong Prov Peoples Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
[7] Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
leptomeningeal carcinomatosis; alectinib resistance; Osimertinib;
D O I：
10.1016/j.jtho.2019.08.1841
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-56
引用
收藏
页码：S852 / S853
页数：2
相关论文
共 50 条
  • [21] EML4-ALK rearrangement in primary malignant fibrous histiocytoma of the lung treated with alectinib: A case report
    Zhang, Shuai
    Liao, Xuqiang
    Chen, Jiawei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [22] EML4-ALK Translocation in Lung Cancer: An Institutional Clinical Experience
    Bertino, E. M.
    Zhao, W.
    Villalona-Calero, M.
    Otterson, G. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S532 - S532
  • [23] EML4-ALK fusion lung cancer:: A rare acquired event
    Perner, Sven
    Wagner, Patrick L.
    Demichelis, Francesca
    Mehra, Rohit
    LaFargue, Chris J.
    Moss, Benjamin J.
    Arbogast, Stefanie
    Soltermann, Alex
    Weder, Walter
    Giordano, Thomas J.
    Beer, David G.
    Rickman, David S.
    Chinnaiyan, Arul M.
    Moch, Holger
    Rubin, Mark A.
    NEOPLASIA, 2008, 10 (03): : 298 - 302
  • [24] Endobronchial Metastases in Lung Cancer Harboring EML4-ALK Rearrangement
    Ijichi, Miharu
    Fukuda, Yosuke
    Kashima, Ayaka
    Sagara, Hironori
    INTERNAL MEDICINE, 2023, 62 (13) : 2021 - 2022
  • [25] A Case of Lung Adenocarcinoma Response to Alectinib Harboring a Rare EML4-ALK Variant, Exon 6 of EML4 Fused to Exon 18 of ALK
    Liu, Lirong
    Hou, Fangfang
    Liu, Yufeng
    Li, Wenzhu
    Zhang, Haibo
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (01): : 2 - 6
  • [26] EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer
    Koivunen, Jussi P.
    Mermel, Craig
    Zejnullahu, Kreshnik
    Murphy, Carly
    Lifshits, Eugene
    Holmes, Alison J.
    Choi, Hwan Geun
    Kim, Jhingook
    Chiang, Derek
    Thomas, Roman
    Lee, Jinseon
    Richards, William G.
    Sugarbaker, David J.
    Ducko, Christopher
    Lindeman, Neal
    Marcoux, J. Paul
    Engelman, Jeffrey A.
    Gray, Nathanael S.
    Lee, Charles
    Meyerson, Matthew
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2008, 14 (13) : 4275 - 4283
  • [27] Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK Rearrangement
    Kwon, Ji-Hyun
    Kim, Kui-Jin
    Sung, Ji Hea
    Suh, Koung Jin
    Lee, Ji Yun
    Kim, Ji-Won
    Kim, Se Hyun
    Lee, Jeong-Ok
    Kim, Jin Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Kim, Jee Hyun
    Bang, Soo-Mee
    Kim, Soyeon
    Yoon, Sung-Soo
    Lee, Jong Seok
    CELLS, 2019, 8 (12)
  • [28] Trametinib overcomes KRAS-G12V-induced osimertinib resistance in a leptomeningeal carcinomatosis model of EGFR-mutant lung cancer
    Fukuda, Koji
    Otani, Sakiko
    Takeuchi, Shinji
    Arai, Sachiko
    Nanjo, Shigeki
    Tanimoto, Azusa
    Nishiyama, Akihiro
    Naoki, Katsuhiko
    Yano, Seiji
    CANCER SCIENCE, 2021, 112 (09) : 3784 - 3795
  • [29] Cerivastatin overcomes the acquired resistance to crizotinib in EML4-ALK positive non-small cell lung cancer by controlling YAP activation
    Yun, Miran
    Choi, Hun Mi
    Pyo, Kyoung Ho
    Cho, Byoung Chul
    CANCER RESEARCH, 2017, 77
  • [30] A novel EML4-ALK BIRC6-ALK double fusion variant in lung adenocarcinoma confers sensitivity to alectinib
    Zhong, Jiang-Ming
    Zhang, Gui-Feng
    Lin, Li
    Li, De-Yu
    Liu, Zhen-Hua
    LUNG CANCER, 2020, 145 : 211 - 212
12345